1. Home
  2. NBTX vs SAMG Comparison

NBTX vs SAMG Comparison

Compare NBTX & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • SAMG
  • Stock Information
  • Founded
  • NBTX 2003
  • SAMG 2002
  • Country
  • NBTX France
  • SAMG United States
  • Employees
  • NBTX N/A
  • SAMG N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • SAMG Investment Managers
  • Sector
  • NBTX Health Care
  • SAMG Finance
  • Exchange
  • NBTX Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • NBTX 178.7M
  • SAMG 149.2M
  • IPO Year
  • NBTX 2020
  • SAMG 2013
  • Fundamental
  • Price
  • NBTX $3.41
  • SAMG $14.63
  • Analyst Decision
  • NBTX Strong Buy
  • SAMG
  • Analyst Count
  • NBTX 1
  • SAMG 0
  • Target Price
  • NBTX $8.00
  • SAMG N/A
  • AVG Volume (30 Days)
  • NBTX 7.6K
  • SAMG 64.7K
  • Earning Date
  • NBTX 04-02-2025
  • SAMG 05-08-2025
  • Dividend Yield
  • NBTX N/A
  • SAMG 5.06%
  • EPS Growth
  • NBTX N/A
  • SAMG 4.17
  • EPS
  • NBTX N/A
  • SAMG 1.00
  • Revenue
  • NBTX N/A
  • SAMG $123,651,000.00
  • Revenue This Year
  • NBTX N/A
  • SAMG $9.70
  • Revenue Next Year
  • NBTX $221.06
  • SAMG $7.28
  • P/E Ratio
  • NBTX N/A
  • SAMG $15.81
  • Revenue Growth
  • NBTX N/A
  • SAMG 5.32
  • 52 Week Low
  • NBTX $2.76
  • SAMG $14.26
  • 52 Week High
  • NBTX $7.51
  • SAMG $19.20
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 55.19
  • SAMG 30.83
  • Support Level
  • NBTX $3.26
  • SAMG $15.50
  • Resistance Level
  • NBTX $3.65
  • SAMG $16.23
  • Average True Range (ATR)
  • NBTX 0.19
  • SAMG 0.45
  • MACD
  • NBTX 0.03
  • SAMG 0.03
  • Stochastic Oscillator
  • NBTX 43.75
  • SAMG 10.22

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: